Use of conventional antipsychotics and the cost of treating schizophrenia
- PMID: 12500340
- PMCID: PMC4194719
Use of conventional antipsychotics and the cost of treating schizophrenia
Abstract
This study documents the drug therapy patterns and 1-year treatment costs for 18,833 Medicaid patients with schizophrenia treated with conventional antipsychotic medications in Michigan, Kentucky, Alabama, and Georgia. One in four patients used no antipsychotic, but had total costs that were less than for treated patients (-$2,576, p < .0001); 18 percent of treated patients delayed therapy for at least 1 month and had significantly higher total costs of $3,994 (p < .0001); 41 percent of treated patients changed therapy with similar results (+$4,067, p < .0001). Only 20 percent of patients were compliant with drug therapy but this had no significant impact on total treatment costs.
Figures
Similar articles
-
The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years.Value Health. 2000 May-Jun;3(3):222-31. doi: 10.1046/j.1524-4733.2000.33004.x. Value Health. 2000. PMID: 16464186
-
The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a medicaid population.Value Health. 2004 Jan-Feb;7(1):22-35. doi: 10.1111/j.1524-4733.2004.71272.x. Value Health. 2004. PMID: 14720128
-
Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.Pharmacoeconomics. 2003;21(10):683-97. doi: 10.2165/00019053-200321100-00001. Pharmacoeconomics. 2003. PMID: 12828491
-
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5. Encephale. 2005. PMID: 15959450 Review. French.
-
Relationship between costs and symptoms in schizophrenia patients treated with antipsychotic medication: a review.J Clin Psychiatry. 2004 Jun;65(6):756-65. doi: 10.4088/jcp.v65n0606. J Clin Psychiatry. 2004. PMID: 15291652 Review.
Cited by
-
Factors that influence the prescription of antipsychotics for patients with schizophrenia in china.Clin Psychopharmacol Neurosci. 2011 Dec;9(3):122-8. doi: 10.9758/cpn.2011.9.3.122. Epub 2011 Dec 31. Clin Psychopharmacol Neurosci. 2011. PMID: 23429971 Free PMC article.
-
Cost-of-illness studies : a review of current methods.Pharmacoeconomics. 2006;24(9):869-90. doi: 10.2165/00019053-200624090-00005. Pharmacoeconomics. 2006. PMID: 16942122 Review.
-
Open access to innovative drugs: treatment substitutions or treatment expansion?Health Care Financ Rev. 2004 Spring;25(3):35-53. Health Care Financ Rev. 2004. PMID: 15229995 Free PMC article.
-
Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs.Pharmacoeconomics. 2004;22(1):1-8. doi: 10.2165/00019053-200422010-00001. Pharmacoeconomics. 2004. PMID: 14720078 Review.
References
-
- American Psychiatric Association. Practice Guideline for the Treatment of Patients with Schizophrenia. American Journal of Psychiatry. 1997;154(Suppl. 4) - PubMed
-
- Buckley PF. Treatment of Schizophrenia: Let's Talk Dollars and Sense. American Journal of Managed Care. 1998;4(3):369–383. - PubMed
-
- California's Medical Assistance Program. Annual Statistical Report: Calendar Year 1994. Medical Care Statistics Section, Department of Health Services; Sacramento, CA.: 1995.
-
- California's Medical Assistance Program. Medi-Cal Top 100 Drug Use Report: 1999 Year-to-Date Through June 1999. Medical Care Statistics Section, Department of Health Services; Sacramento, CA.: 1999.
-
- Chassin MR, Brook RH, Park RE, et al. Variations in the Use of Medical and Surgical Services by the Medicare Population. New England Journal of Medicine. 1986;314(5):285–290. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical